Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer

BackgroundHypoxia-inducible factor 1-alpha (HIF-1α) stability and transcriptional action are reduced by the hypoxia-inducible factor 1-alpha subunit suppressor (HIF1AN). Its inappropriate expression is associated with the development of cancer and immune control. It is yet unknown how HIF1AN, clinic...

Full description

Bibliographic Details
Main Authors: Shasha Tang, Dongyang Liu, Yuan Fang, Liyun Yong, Yi Zhang, Mengying Guan, Xiaoyan Lin, Hui Wang, Fengfeng Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1080910/full
_version_ 1797934933977595904
author Shasha Tang
Dongyang Liu
Yuan Fang
Liyun Yong
Yi Zhang
Mengying Guan
Xiaoyan Lin
Hui Wang
Fengfeng Cai
author_facet Shasha Tang
Dongyang Liu
Yuan Fang
Liyun Yong
Yi Zhang
Mengying Guan
Xiaoyan Lin
Hui Wang
Fengfeng Cai
author_sort Shasha Tang
collection DOAJ
description BackgroundHypoxia-inducible factor 1-alpha (HIF-1α) stability and transcriptional action are reduced by the hypoxia-inducible factor 1-alpha subunit suppressor (HIF1AN). Its inappropriate expression is associated with the development of cancer and immune control. It is yet unknown how HIF1AN, clinical outcomes, and immune involvement in breast cancer (BC) are related.MethodsUsing the GEPIA, UALCAN, TIMER, Kaplan-Meier plotter, and TISIDB datasets, a thorough analysis of HIF1AN differential expression, medical prognosis, and the relationship between HIF1AN and tumor-infiltrating immune cells in BC was conducted. Quantitative real-time PCR (qRT−PCR) analysis of BC cells were used for external validation.ResultsThe findings revealed that, as compared to standard specimens, BC cells had significantly lower levels of HIF1AN expression. Good overall survival (OS) for BC was associated with higher HIF1AN expression. Additionally, in BC, the expression of HIF1AN was closely associated with the chemokines and immune cell infiltration, including neutrophils, macrophages, T helper cells, B cells, Tregs, monocytes, dendritic cells, and NK cells. A high correlation between HIF1AN expression and several immunological indicators of T-cell exhaustion was particularly revealed by the bioinformatic study.ConclusionsHIF1AN is a predictive indicator for breast tumors, and it is useful for predicting survival rates.
first_indexed 2024-04-10T18:07:45Z
format Article
id doaj.art-f6fabb9fd9ce44c0843f200d6100d520
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T18:07:45Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-f6fabb9fd9ce44c0843f200d6100d5202023-02-02T12:45:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-02-011310.3389/fonc.2023.10809101080910Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancerShasha Tang0Dongyang Liu1Yuan Fang2Liyun Yong3Yi Zhang4Mengying Guan5Xiaoyan Lin6Hui Wang7Fengfeng Cai8Department of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Breast Surgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Breast Surgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Breast Surgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, ChinaLaboratory of Tumor Molecular Biology, School of Basic Medical Sciences, Shanghai University of Medicine and Health Sciences, Shanghai, ChinaDepartment of Breast Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, ChinaBackgroundHypoxia-inducible factor 1-alpha (HIF-1α) stability and transcriptional action are reduced by the hypoxia-inducible factor 1-alpha subunit suppressor (HIF1AN). Its inappropriate expression is associated with the development of cancer and immune control. It is yet unknown how HIF1AN, clinical outcomes, and immune involvement in breast cancer (BC) are related.MethodsUsing the GEPIA, UALCAN, TIMER, Kaplan-Meier plotter, and TISIDB datasets, a thorough analysis of HIF1AN differential expression, medical prognosis, and the relationship between HIF1AN and tumor-infiltrating immune cells in BC was conducted. Quantitative real-time PCR (qRT−PCR) analysis of BC cells were used for external validation.ResultsThe findings revealed that, as compared to standard specimens, BC cells had significantly lower levels of HIF1AN expression. Good overall survival (OS) for BC was associated with higher HIF1AN expression. Additionally, in BC, the expression of HIF1AN was closely associated with the chemokines and immune cell infiltration, including neutrophils, macrophages, T helper cells, B cells, Tregs, monocytes, dendritic cells, and NK cells. A high correlation between HIF1AN expression and several immunological indicators of T-cell exhaustion was particularly revealed by the bioinformatic study.ConclusionsHIF1AN is a predictive indicator for breast tumors, and it is useful for predicting survival rates.https://www.frontiersin.org/articles/10.3389/fonc.2023.1080910/fullbreast cancerhypoxia-inducible factor 1-alpha subunit inhibitor (HIF1AN)prognosisimmune infiltrating cellbiomarker
spellingShingle Shasha Tang
Dongyang Liu
Yuan Fang
Liyun Yong
Yi Zhang
Mengying Guan
Xiaoyan Lin
Hui Wang
Fengfeng Cai
Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
Frontiers in Oncology
breast cancer
hypoxia-inducible factor 1-alpha subunit inhibitor (HIF1AN)
prognosis
immune infiltrating cell
biomarker
title Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
title_full Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
title_fullStr Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
title_full_unstemmed Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
title_short Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
title_sort low expression of hif1an accompanied by less immune infiltration is associated with poor prognosis in breast cancer
topic breast cancer
hypoxia-inducible factor 1-alpha subunit inhibitor (HIF1AN)
prognosis
immune infiltrating cell
biomarker
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1080910/full
work_keys_str_mv AT shashatang lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer
AT dongyangliu lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer
AT yuanfang lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer
AT liyunyong lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer
AT yizhang lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer
AT mengyingguan lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer
AT xiaoyanlin lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer
AT huiwang lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer
AT fengfengcai lowexpressionofhif1anaccompaniedbylessimmuneinfiltrationisassociatedwithpoorprognosisinbreastcancer